Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

New insights in the mechanism of the SARS-CoV-2 Mpro inhibition by benzisoselenazolones and diselenides

  • Sancineto, Luca
  • Mangiavacchi, Francesca
  • Dabrowska, Agnieszka
  • Pacuła-Miszewska, Agata J.
  • Obieziurska-Fabisiak, Magdalena
  • Scimmi, Cecilia
  • Ceccucci, Veronica
  • Kong, Juan
  • Zhao, Yao
  • Ciancaleoni, Gianluca
  • Nascimento, Vanessa
  • Rizzuti, Bruno
  • Bortoli, Marco
  • Orian, Laura
  • Kula-Pacurar, Anna
  • Yang, Haitao
  • Ścianowski, Jacek
  • Lei, Ying
  • Pyrc, Krzysztof
  • Santi, Claudio
Although global vaccination campaigns alleviated the SARS-CoV-2 pandemic in terms of morbidity and mortality, the ability of the virus to originate mutants may reduce the efficacy of vaccines, posing a serious risk of a renewed pandemic. There is therefore a need to develop small molecules capable of targeting conserved viral targets, such as the main protease (Mpro). Here, a series of benzisoselenazolones and diselenides were tested for their ability to inhibit Mpro; then the most potent compounds were measured for antiviral activity in vitro, and the mechanism of action was investigated. Density functional theory calculations, molecular docking and molecular dynamics simulations were also used to elucidate the protein/drug interaction. Finally, a bio-organic model was established to study the reaction between selenorganic compounds and biologically relevant thiols to unveil possible metabolic pathways of such compounds. The overall results contribute to the identification of a series of novel Se-containing molecules active against SARS-CoV-2 and to the clarification of some important aspects in the mechanisms of action of such inhibitors targeting SARS-CoV-2 Mpro., (CS) This research was supported by Department of Pharmaceutical Sciences with the project DELPHI “Dipartimenti di Eccellenza 2018–2022” and by University of Perugia with project “Ricerca di Base”. (KP) This work was supported by the DURABLE project, co-funded by the European Union, under the EU4Health Programme (EU4H) (https://health.ec.europa.eu/funding/eu4health-programme-2021-2027-vision-healthiereuropean-union_en#work-programmes), and ERAnet ICRAD—project Musecov: Multiscale Eco-evolution of Coronaviruses: from surveillance toward emergence prediction (https://www.era-learn.eu/network-information/networks/icrad/1st-icrad-call-2019/multiscale-eco-evolution-of-coronaviruses-from-surveillance-toward-emergence-prediction)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Microbiota Signatures in Early Life and Their Association With Food Allergy: A Systematic Review

  • Flores Ventura, Eduard
  • Corriger, Jeremy
  • Omer, Hélène
  • Bodinier, Marie
  • Haller, Dirk
  • Hertz, Tomer
  • Larsen, Martin
  • Collado, María Carmen
Food allergy (FA) is increasing worldwide, and early life may be a critical window for immune training. We systematically reviewed observational human studies linking early-life microbiota (infant, maternal, environmental, or extraintestinal) profiled using culture-based and/or culture-independent methods (including sequencing-based approaches) to subsequent FA or food sensitization outcomes in infants, children, and adolescents up to 18 years of age. PubMed, Web of Science Core Collection, Embase, Scopus, and LILACS were searched from database inception to March 2026. Inclusion required microbiota sampling during pregnancy or childhood and clinically ascertained FA/sensitization; non-human studies and studies without sequencing or clinical outcomes were excluded. Risk of bias was assessed using QUIPS. Owing to heterogeneity, we performed narrative synthesis. Forty studies were included (n = 6530 participants; 2077 cases). Across cohorts, cases were associated with lower diversity, early beta-divergence (1-6 months), neonatal enrichment of Proteobacteria (Pseudomonadota)/Enterobacteriaceae and selected taxa (Clostridium, Streptococcus, Sutterella), and depletion within the first year of Bifidobacterium, Blautia, and butyrate producers (Roseburia, Faecalibacterium). Functional profiles often suggested delayed maturation and reduced short-chain fatty acid capacity. Evidence was limited by moderate risk of bias, residual confounding, and heterogeneous outcome definitions. These findings support distinct early-life microbial configurations associated with FA susceptibility versus tolerance, informing mechanism-based prevention. Trial Registration: PROSPERO CRD420251234739., The work was supported by a European grant (Physiological and Ecological impact of pre- and probiotic interventions in relation to food allergy in early-life, EcoBIOTIC), ERA-HDHL (2021: Food Hypersens—Addressing adverse and beneficial effects of food ingredients and food processing on hypersensitivities to food), Joint Action ‘European Joint Programming Initiative “A Healthy Diet for a Healthy Life” (JPI-HDHL)’—FOOD-HYPERSENS call and the national funding from Programación Conjunta Internacional (PCI) (ref. PCI2021-122059-2A), Spain (E.F.V. and M.C.C.). J.C. and M.L. were supported by EarlyFOOD (ANR-17-HDIM-0002) and EcoBIOTIC (ANR-20-CE15-0032) both JPI HDHL Era-Net. D.H. and H.O. were supported by the German Federal Ministry of Research, Technology and Space (BMFTR, previously BMBF; FKZ 01EA2207)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001189-S)., Peer reviewed